Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
4 Questions About Biosimilars in Inflammatory Bowel Disease
07/17/2019
Stephen Hanauer, MD, from Northwestern Medicine, answers our questions about the use of biosimilars in the management of IBD ahead of his presentation at the Advances in Inflammatory Bowel Diseases (AIBD) Regional Meeting in Chicago.
Stephen Hanauer, MD, from Northwestern Medicine, answers our questions about the use of biosimilars in the management of IBD ahead of his presentation at the Advances in Inflammatory Bowel Diseases (AIBD) Regional Meeting in Chicago.
Stephen Hanauer, MD, from...
07/17/2019
Advances in Inflammatory Bowel Disease Network
News
Anti‐TNF-α Therapy May Increase Risk of Inflammatory Bowel Disease
07/10/2019
Researchers evaluated data on more than 17,000 individuals with an autoimmune disease who received treatment with an anti-tumor necrosis factor α agent to determine the risk of developing new inflammatory bowel disease.
Researchers evaluated data on more than 17,000 individuals with an autoimmune disease who received treatment with an anti-tumor necrosis factor α agent to determine the risk of developing new inflammatory bowel disease.
Researchers evaluated data on...
07/10/2019
Advances in Inflammatory Bowel Disease Network
News
Miguel Regueiro, MD, on Treating IBD: Time is of the Essence
06/15/2019
Because of its potential to lead to serious consequences, the inadequate treatment of inflammatory bowel disease can be viewed as an adverse event, according to Miguel Regueiro, MD, from Cleveland Clinic. The need for timely, optimal...
Because of its potential to lead to serious consequences, the inadequate treatment of inflammatory bowel disease can be viewed as an adverse event, according to Miguel Regueiro, MD, from Cleveland Clinic. The need for timely, optimal...
Because of its potential to lead...
06/15/2019
Advances in Inflammatory Bowel Disease Network

Advertisement

News
Emerging Therapies in Crohn Disease: What to Expect
06/15/2019
Russell Cohen, MD, from the University of Chicago Pritzker School of Medicine, highlights recent and emerging therapies for Crohn disease during one of his sessions at the AIBD Regionals Meeting in Boston.
Russell Cohen, MD, from the University of Chicago Pritzker School of Medicine, highlights recent and emerging therapies for Crohn disease during one of his sessions at the AIBD Regionals Meeting in Boston.
Russell Cohen, MD, from the...
06/15/2019
Advances in Inflammatory Bowel Disease Network
News
Infection in the First Year of Life Increases IBD Risk in the Long Term
06/11/2019
By analyzing more than 40 years of data, authors of a new study determined whether certain events and socioeconomic factors from an individual’s first year of life can impact the risk of developing IBD later in life.
By analyzing more than 40 years of data, authors of a new study determined whether certain events and socioeconomic factors from an individual’s first year of life can impact the risk of developing IBD later in life.
By analyzing more than 40 years...
06/11/2019
Advances in Inflammatory Bowel Disease Network
News
Risk for VTE Remains in Patients With IBD After Hospitalization
05/13/2019
Patients with inflammatory bowel disease have an increased risk for venous thromboembolism during hospitalization. Researchers in Ontario, Canada, sought to determine whether the risk continues after hospital discharge.
Patients with inflammatory bowel disease have an increased risk for venous thromboembolism during hospitalization. Researchers in Ontario, Canada, sought to determine whether the risk continues after hospital discharge.
Patients with inflammatory bowel...
05/13/2019
Advances in Inflammatory Bowel Disease Network

Advertisement

News
4 Questions on the Updated ACG Guidelines for Managing UC
04/18/2019
David T. Rubin, MD, lead author of the ACG Clinical Guideline: Ulcerative Colitis in Adults, answers our questions about what’s new in the guidelines for the management of adults with ulcerative colitis.
David T. Rubin, MD, lead author of the ACG Clinical Guideline: Ulcerative Colitis in Adults, answers our questions about what’s new in the guidelines for the management of adults with ulcerative colitis.
David T. Rubin, MD, lead author...
04/18/2019
Advances in Inflammatory Bowel Disease Network
News
Early Combined Immunosuppression Appears Safe in Elderly With Crohn Disease
04/16/2019
Researchers analyzed results of the REACT clinical trial to determine whether age affects the safety and efficacy of early combined immunosuppressive treatment in Crohn disease.
Researchers analyzed results of the REACT clinical trial to determine whether age affects the safety and efficacy of early combined immunosuppressive treatment in Crohn disease.
Researchers analyzed results of...
04/16/2019
Advances in Inflammatory Bowel Disease Network
News
Proactive Care Is Essential for IBD Management
04/06/2019
From treating a patient’s current disease state to treating based on a patient’s future disease risk, managing IBD has evolved over the years. It was the keynote topic at the AIBD Regional Meeting in Los Angeles.
From treating a patient’s current disease state to treating based on a patient’s future disease risk, managing IBD has evolved over the years. It was the keynote topic at the AIBD Regional Meeting in Los Angeles.
From treating a patient’s...
04/06/2019
Advances in Inflammatory Bowel Disease Network

Advertisement

News
5 Questions About Therapeutic Drug Monitoring in IBD
04/02/2019
Therapeutic drug monitoring has the potential to optimize inflammatory bowel disease management. Siddharth Singh, MD, MS, answers our questions about this important topic in advance of his presentation at the Advances in Inflammatory Bowel...
Therapeutic drug monitoring has the potential to optimize inflammatory bowel disease management. Siddharth Singh, MD, MS, answers our questions about this important topic in advance of his presentation at the Advances in Inflammatory Bowel...
Therapeutic drug monitoring has...
04/02/2019
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use